In the early course of RA, the appearance of anti-citrulline antibodies (ACPA) and anti-citrullinated fibrinogen antibodies (ACF) suggests that joint inflammation will be more severe in antibody-negative patients, and the loss of tolerance to citrullinated proteins in RA patients exacerbates the development of the disease. Here, PRTN3 is linked to rheumatoid arthritis.